Metformin

Clinical trials for chronic conditions involve personal and practical considerations, requiring participants to weigh long-term benefits against immediate disruptions. Motivations include personal benefits, altruism, and trust in healthcare providers, while barriers include fear, stigma, and logistical challenges. Addressing these requires patient-centered approaches, including emotional support, flexible trial designs, and culturally sensitive outreach.

Promise Bio announces $8.3M seed funding to develop a platform integrating epiproteomics and AI for personalized treatments and drug development.

Five Bali Nine members returned to Australia after 20 years in Indonesian prisons, expressing gratitude to President Prabowo Subianto. They were provided temporary accommodation for resettlement and are now free to live in Australia.

Healthcare's need for real world evidence (RWE) is growing, driven by stakeholders seeking insights into drug effects. Technological advancements have improved data collection, enabling higher-quality RWE from patient registries. These registries now integrate diverse data sources and digital technologies, enhancing patient participation and data quality. Four trends—decentralised clinical trials, wearable devices, enhanced data sharing, and data linkage—are transforming registries into strategic RWE assets.

AI in pharma addresses R&D costs, supply chain complexity, and data management by accelerating drug development, automating compliance, managing large datasets, and optimizing clinical trials. Swiss startup Risklick uses AI to streamline clinical trial protocols and integrate historical data. As AI evolves, stakeholders must integrate these innovations to optimize research, enhance data-driven decisions, and meet patient needs.

The global AI in Medical Writing Market is projected to grow from USD 799.2 Million in 2023 to USD 2598.7 Million by 2033, driven by advancements in NLP and ML, government initiatives, and demand for personalized medicine. AI tools streamline clinical documentation, regulatory submissions, and scientific writing, addressing challenges like data privacy and ethical issues through evolving regulatory frameworks.

Large language models pose risks in scientific research due to hallucination rates, prompting concerns among researchers. Retrieval Augmented Generation (RAG) enhances trustworthiness by grounding AI with external data sources, aiding in data provenance. Precision engineering and human oversight are crucial for reliable AI implementation, ensuring accuracy and reproducibility. The evolution of AI tools aims to augment human researchers, maintaining human centrality in decision-making while prioritizing data quality and security.

Mitotic waves transition from phase waves to trigger waves in Xenopus laevis egg extracts, characterized by a shift from synchronous, fast-moving early patterns to linear, slow-moving later patterns. The transition is quantified by measuring period and wave speed, revealing a two-step process with an initial fast decay followed by a slower transition to a terminal speed. Nuclei and external driving via cytostatic-factor (CSF) extract accelerate this transition, acting as pacemakers and promoting spatial heterogeneity, respectively. The study highlights the role of spatial heterogeneity in entraining the system to the trigger wave regime, distinguishing trigger waves' stable speed from phase waves' arbitrary speed.

Philips' advanced diagnostic and treatment solutions, coupled with healthcare informatics, uniquely position the company to drive precision imaging for more patients, enhancing patient outcomes through intelligent technologies and data-driven insights.

AI revolutionizes pharmacovigilance and clinical research by enhancing data processing, decision-making, and drug development, addressing traditional method limitations. AI tools like ARIS G and ARGUS improve case management, signal detection, and risk management, ensuring faster and more accurate drug safety monitoring. In clinical research, AI optimizes trial design, patient recruitment, and real-time data analysis, accelerating drug development. Ethical and regulatory considerations are crucial as AI systems evolve, requiring transparent, responsible use of AI in healthcare.